Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free
free
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll An evidence-based update on nonsteroidal anti-inflammatory drugs Ong CK; Lirk P; Tan CH; Seymour RAClin Med Res 2007[Mar]; 5 (1): 19-34Nonsteroidal anti-inflammatory drugs (NSAIDs), including both traditional nonselective NSAIDs and the selective cyclooxygenase (COX)-2 inhibitors, are widely used for their anti-inflammatory and analgesic effects. NSAIDs are a necessary choice in pain management because of the integrated role of the COX pathway in the generation of inflammation and in the biochemical recognition of pain. This group of drugs has recently come under scrutiny because of recent focus in the literature on the various adverse effects that can occur when applying NSAIDs. This review will provide an educational update on the current evidence of the efficacy and adverse effects of NSAIDs. It aims to answer the following questions: (1) are there clinically important differences in the efficacy and safety between the different NSAIDs, (2) if there are differences, which are the ones that are more effective and associated with fewer adverse effects, and (3) which are the effective therapeutic approaches that could reduce the adverse effects of NSAIDs. Finally, an algorithm is proposed which delineates a general decision-making tree to select the most appropriate analgesic for an individual patient based on the evidence reviewed.|Algorithms[MESH]|Analgesics/metabolism[MESH]|Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use[MESH]|Cardiovascular Diseases/etiology[MESH]|Cyclooxygenase 2 Inhibitors/therapeutic use[MESH]|Evidence-Based Medicine/*methods[MESH]|Gastrointestinal Tract/drug effects[MESH]|Humans[MESH]|Pain Management[MESH]|Pain/drug therapy[MESH]|Research Design[MESH]|Risk[MESH]|Risk Factors[MESH]|Treatment Outcome[MESH] |